Portfolio Design Labs LLC Increases Position in UnitedHealth Group Incorporated (NYSE:UNH)

Portfolio Design Labs LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 21.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,929 shares of the healthcare conglomerate’s stock after buying an additional 1,557 shares during the quarter. UnitedHealth Group accounts for 0.9% of Portfolio Design Labs LLC’s investment portfolio, making the stock its 24th largest holding. Portfolio Design Labs LLC’s holdings in UnitedHealth Group were worth $4,517,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $30,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group in the third quarter valued at about $37,000. Friedenthal Financial acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $51,000. DecisionPoint Financial LLC raised its position in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after buying an additional 62 shares during the last quarter. Finally, Highline Wealth Partners LLC acquired a new stake in UnitedHealth Group during the third quarter worth approximately $55,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

UNH has been the topic of several analyst reports. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. KeyCorp reiterated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. TD Cowen upped their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $629.32.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $533.99 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a fifty day moving average of $527.67 and a two-hundred day moving average of $564.22. The firm has a market cap of $491.42 billion, a P/E ratio of 34.45, a P/E/G ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the business earned $5.83 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.